Publicacions en què col·labora amb EDUARDO DÍAZ-RUBIO GARCÍA (7)

2014

  1. Assignment of tumor subtype by genomic testing and pathologic-based approximations: Implications on patient's management and therapy selection

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 386-394

2013

  1. Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients

    Annals of Oncology, Vol. 24, Núm. 3, pp. 655-661

2012

  1. Glutathione S-transferase P1 c.313a > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients

    Annals of Oncology, Vol. 23, Núm. 7, pp. 1750-1756

2011

  1. Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

    Breast Cancer Research and Treatment, Vol. 128, Núm. 1, pp. 127-136

2005

  1. The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families

    Familial Cancer, Vol. 4, Núm. 2, pp. 183-186

1999

  1. Prognostic factors in invasive lobular carcinoma of the breast: A multivariate analysis. A multicentre study after seventeen years of follow-up

    Annales Chirurgiae et Gynaecologiae, Vol. 88, Núm. 4, pp. 252-258

1989

  1. Lethal cardiac toxicity after cisplatin and 5-fluorouracil chemotherapy. Report of a case with necropsy study

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 12, Núm. 3, pp. 229-234